You are here

Effect of Prevnar 13 on Ear Infections in Children

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Penfield Pediatrics
Penfield, New York, 14526 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Otitis Media
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
6-30 months
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subject has received full (3-dose) infant series of Prevnar 13

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Prior vaccination with any 7vPnC.

- Prior vaccination with 23-valent pneumococcal polysaccharide vaccine (23vPS).

- Any major illness/condition that, in the investigator's judgment, will substantially
increase the risk associated with the subject's participation in the study.

NCT01199016
Pfizer
Completed
Effect of Prevnar 13 on Ear Infections in Children

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now